NewAmsterdam Pharma Co NV (NAMS)
16.23
+0.40
(+2.53%)
USD |
NASDAQ |
Sep 27, 16:00
16.26
+0.04
(+0.22%)
After-Hours: 20:00
NewAmsterdam Pharma Profit Margin (Quarterly): -1.71K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -1.71K% |
March 31, 2024 | -6.69K% |
Date | Value |
---|---|
June 30, 2023 | -2.23K% |
March 31, 2023 | -486.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.69K%
Minimum
Mar 2024
-486.9%
Maximum
Mar 2023
-2.78K%
Average
-1.97K%
Median
Profit Margin (Quarterly) Benchmarks
Koninklijke Philips NV | -24.14% |
uniQure NV | -506.0% |
ProQR Therapeutics NV | -42.70% |
Merus NV | -682.5% |
argenx SE | 6.09% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -56.65% |
Return on Assets | -44.17% |
Return on Invested Capital | -50.81% |
Operating Margin (Quarterly) | -2.26K% |
Return on Net Operating Assets | -44.18% |